comparemela.com

Latest Breaking News On - Standigm insight - Page 1 : comparemela.com

Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery

/PRNewswire/ Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the appointment of Chief.

Seoul
Soult-ukpyolsi
South-korea
Cambridge
Cambridgeshire
United-kingdom
Netherlands
Oxford-glycosciences
Carl-foster
Jinhan-kim
University-of-kansas
Praecis-pharmaceuticals

Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease

Standigm Expands Global Footprints with New Office in Cambridge, UK

SEOUL, South Korea, Aug. 20, 2021 /PRNewswire/ Standigm, a leading workflow AI drug discovery company, today announced the opening of a new office in Cambridge, United Kingdom ("UK"), to

Seoul
Soult-ukpyolsi
South-korea
Cambridgeshire
United-kingdom
Cambridge
Hee-jung-koo
Kostenloser-wertpapierhandel
Prnewswire-standigm
University-of-cambridge
Milner-therapeutics-institute
Standigm-insight

Standigm secures SI investment for expanding its AI-drug development capacity

Standigm secures SI investment for expanding its AI-drug development capacity
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Jeong-hoon-kim
Jinhan-kim
Standigm-synthesis-research-center
Sk-chemicals-co-ltd
Standigm-inc
Synthesis-research-center
Standigm-insight
ஜியோங்-ஹூன்-கிம்
ஸ்க்-இரசாயனங்கள்-இணை-லிமிடெட்

Standigm Raises $10M in Funding

Standigm Raises $10M in Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Seoul
Soult-ukpyolsi
South-korea
Jinhan-kim
Standigm-inc
South-korea-based
Standigm-insight
சியோல்
தெற்கு-கொரியா
தெற்கு-கொரியா-அடிப்படையிலானது
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.